Aligos Therapeutics, Inc.ALGSNASDAQ
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-98.69%
↓ 171% below average
Average (28q)
-36.48%
Historical baseline
Range
High:139.14%
Low:-479.01%
Volatility
-1694.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -98.69% |
| Q2 2025 | -129.88% |
| Q1 2025 | 139.14% |
| Q4 2024 | -326.06% |
| Q3 2024 | -479.01% |
| Q2 2024 | 136.16% |
| Q1 2024 | -100.00% |
| Q4 2023 | -173.17% |
| Q3 2023 | 4.65% |
| Q2 2023 | 18.87% |
| Q1 2023 | -3.92% |
| Q4 2022 | -15.91% |
| Q3 2022 | 6.38% |
| Q2 2022 | 44.05% |
| Q1 2022 | 5.62% |
| Q4 2021 | -14.10% |
| Q3 2021 | 1.27% |
| Q2 2021 | -6.76% |
| Q1 2021 | 32.11% |
| Q4 2020 | -21.11% |
| Q3 2020 | 5.26% |
| Q2 2020 | -4.40% |
| Q1 2020 | -9.64% |
| Q4 2019 | -29.69% |
| Q3 2019 | -39.13% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |